Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

3.06
Delayed Data
As of Sep 29
 +0.57 / +22.89%
Today’s Change
1.23
Today|||52-Week Range
16.63
-69.70%
Year-to-Date
Institutional investors purchased a net $4.4 million shares of AEGR during the quarter ended June 2016, and now own 89.09% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Other institutional71.20%
Individual stakeholders51.99%
Mutual fund holders17.89%

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

Top 10 Owners of Aegerion Pharmaceuticals Inc

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change

Top 10 Mutual Funds Holding Aegerion Pharmaceuticals Inc

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Fidelity Select Biotechnology Por...6.37%1,880,7493,065,62100.00%
Fidelity Advisor Biotechnology Fu...3.32%978,8231,595,48100.00%
Vanguard Total Stock Market Index...1.92%565,608921,94100.00%
iShares Nasdaq Biotechnology ETF1.36%400,912653,487+1,530+0.38%
Vanguard Extended Market Index Fu...1.19%350,486571,29200.00%
Vanguard Institutional Total Stoc...0.60%176,216287,23200.00%
Fidelity Spartan Extended Market ...0.42%123,636201,52700.00%
Federated MDT Small Cap Growth Fu...0.40%117,236191,095+19,046+19.40%
AMG Managers Special Equity Fund0.36%107,266174,84400.00%
iShares Micro Cap ETF0.24%70,619115,10900.00%